A Systematic Approach for Liposome and Lipodisk Preclinical Formulation Development by Microfluidic Technology
- 14 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 23 (6), 1-12
- https://doi.org/10.1208/s12248-021-00651-4
Abstract
Lipid nanoparticles have transformed the drug delivery field enhancing the therapeutic drug performance of small molecules and biologics with several approved drug products. However, in industry, these more complex drug delivery systems such as liposomes require more material and time to develop. Here, we report a liposome and lipodisk decision tree with model compounds of diverse physicochemical properties to understand how to resourcefully optimize encapsulation efficiency (EE) for these lipid-based drug delivery systems. We have identified trends with physicochemical properties such as Log P, where higher Log P compounds such as curcumin were able to efficiently load into the lipid bilayer resulting in high EE with altering the drug/lipid (D/L) ratio. Moderate Log P compounds such as cyclosporine A and dexamethasone had significantly higher encapsulation in lipodisks, which contain higher amounts of PEG lipid compared to liposomes. The EE of negative Log P compounds, like acyclovir, remained low regardless of altering the D/L ratio and PEG concentrations. In this study, microfluidic techniques were employed to fabricate liposomes and lipodisks formulations allowing for a reproducible strategy for formulation development. Both liposome and lipodisk of curcumin demonstrated enhanced in vivo performance compared with a conventional formulation in the rat pharmacokinetic study. This combination of approaches with multiple model compounds and lipid-based drug delivery systems provides a systematic guidance to effective strategies to generate higher EE with minimal drug waste and expedite the process for preclinical development when applied to industry compounds.Keywords
This publication has 64 references indexed in Scilit:
- Liposome: classification, preparation, and applicationsNanoscale Research Letters, 2013
- Quantitative structure - property relationship modeling of remote liposome loading of drugsJournal of Controlled Release, 2012
- Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacyInternational Journal of Nanomedicine, 2011
- Development of stealth liposome coencapsulating doxorubicin and fluoxetineJournal of Liposome Research, 2011
- Effects of Drug Hydrophobicity on Liposomal StabilityChemical Biology & Drug Design, 2007
- Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradientBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulationsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle methodInternational Journal of Pharmaceutics, 2005
- Liposomes in drug delivery: Progress and limitationsInternational Journal of Pharmaceutics, 1997
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965